where he spent 19 years responsible for surface exploration
in northeastern Ontario and underground exploration at
Hoyle Pond, currently the highest grade gold mine in
the Timmins Camp.
Gold - Spot Price (EOD) ($GOLD)mthly bolly 10,2 -
Click on the chart to enlarge it.
Gold - Spot Price (EOD) ($GOLD)aden labeling -
Gold - Spot Price (EOD) ($GOLD)Bull Channel -
Gold - Spot Price (EOD) ($GOLD)bullmarkets quarterly -
Gold - Spot Price (EOD) ($GOLD)bullhorn to heaven -
Moneta Porcupine Mines Inc. (ME) Est. 1910 -
Exchange: Toronto Stock Exchange
Moneta started a bull run -
Moneta intersects 2.02 g/t gold over 114.5 metres in volcanics near Golden Highway pit resource
TORONTO, Feb. 28, 2014 /CNW/ -
Moneta Porcupine Mines Inc.
(TSX: ME) (OTC: MPUCF) (XETRA: MOP) ("Moneta" or the "Company")
is pleased to report drill results from its 100% owned
Golden Highway property in Timmins, Ontario.
Drill hole MGH13-077 intersected consistent gold grades over
a large, shallow mineralized interval, as follows:
http://www.monetaporcupine.com/s/Home.asp
http://www.monetaporcupine.com/s/Presentation.asp
http://www.monetaporcupine.com/i/pdf/Moneta-Mar2014-PDAC.pdf
http://web.tmxmoney.com/article.php?newsid=66085886&qm_symbol=ME
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=97940248
http://web.tmxmoney.com/quote.php?qm_symbol=ME
PDAC 2014
Gold- Exploration
Monday, March 3, 2014, 9:55 AM - 12:00 PM
Chair: Tara Hassan, Haywood Securities Inc.
Location: Room 802AB
Introduction
Moneta Porcupine Mines Inc.
11:00 AM - 11:20 AM Add to Calendar
Ken D. Tylee
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=96269468
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=97455332
God Bless
Recent ME News
- 23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- 23andMe announces CEO’s intention to pursue a potential take-private • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- 23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 • GlobeNewswire Inc. • 04/05/2024 08:05:00 PM
- 23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 • GlobeNewswire Inc. • 03/20/2024 11:30:00 AM
- 23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago • GlobeNewswire Inc. • 03/19/2024 12:00:00 PM
- 23andMe Launches New Genetic Reports on Common Forms of Cancer • GlobeNewswire Inc. • 03/06/2024 12:30:00 PM
- 23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:36:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 09:07:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:03:56 PM
- 23andMe Reports Third Quarter Fiscal 2024 Financial Results • GlobeNewswire Inc. • 02/07/2024 09:01:00 PM
- Moneta Gold and Nighthawk Gold Complete At-Market Merger to form STLLR Gold Inc. • Business Wire • 02/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 12:50:09 PM
- 23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay • GlobeNewswire Inc. • 01/31/2024 03:12:36 AM
- Nighthawk Gold Obtains Final Court Order for the Proposed Arrangement • Business Wire • 01/30/2024 10:00:00 PM
- 23andMe to Report FY2024 Third Quarter Financial Results • GlobeNewswire Inc. • 01/24/2024 09:05:00 PM
- Moneta Gold and Nighthawk Gold Announce the Proposed Directors for the MergeCo Board • Business Wire • 01/22/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:45:21 PM
- 23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts • GlobeNewswire Inc. • 12/19/2023 01:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/01/2023 09:06:04 PM
- Nighthawk and Moneta Announce At-Market Merger to Create a Leading Canadian Gold Development Company • Business Wire • 11/28/2023 12:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:41:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:40:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:06:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:29:40 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM